Sex Hormone: A Potential Target at Treating Female Metabolic Dysfunction-Associated Steatotic Liver Disease?
- 19 November 2024
- journal article
- review article
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (2) , 102459
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82270855)
This publication has 192 references indexed in Scilit:
- New insights into the role and mechanism of c‐Jun‐N‐terminal kinase signaling in the pathobiology of liver diseasesHepatology, 2017
- c‐Jun N‐terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)‐dependent pathway leading to inactivation of intramitochondrial SrcHepatology, 2016
- Nonalcoholic Fatty Liver DiseaseJAMA, 2015
- Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized TrialsJAMA, 2013
- Prediagnostic plasma testosterone, sex hormone‐binding globulin, IGF‐I and hepatocellular carcinoma: Etiological factors or risk markers?International Journal of Cancer, 2013
- Hepatic-specific activation of peroxisome proliferator-activated receptor γ coactivator-1β protects against steatohepatitisHepatology, 2013
- Adiponectin Regulation and Function2011
- A novel pregnane X receptor and S14‐mediated lipogenic pathway in human hepatocyte†Hepatology, 2009
- Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?Diabetes/Metabolism Research and Reviews, 2008
- Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in miceHepatology, 2004